Westbrook, CT, United States of America

Mark Stephen Plummer

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2014-2024

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Mark Stephen Plummer: Innovations in Antibacterial Agents

Introduction: Mark Stephen Plummer is a notable inventor based in Westbrook, CT, USA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of new antibacterial agents. With three patents to his name, Plummer is recognized for his innovative approach to combating bacterial infections through the creation of fluoro-pyridinone derivatives.

Latest Patents: Plummer's latest patents focus on the development of fluoro-pyridinone phosphates and boronates that serve as effective antibacterial agents. His first patent, titled "Fluoro-pyridinone phosphates and boronates useful as antibacterial agents," introduces a new class of hydroxamic acid phosphates and boronates. These compounds are designed to act as LpxC inhibitors, proving useful in the treatment of bacterial infections. The specific formulae outlined in the patent highlight various structural components that enhance the compounds' efficacy against harmful bacteria. Additionally, his second patent, "Fluoro-pyridinone derivatives useful as antibacterial agents," continues this line of research by expanding on the hydroxamic acid derivatives and their capabilities as LpxC inhibitors.

Career Highlights: Mark Plummer has established a prominent career with Pfizer Corporation, where his work in pharmaceutical research has significantly advanced the understanding of antibacterial properties. His innovative contributions have positioned him as an essential part of the company's research team, allowing for the development of novel treatments aimed at bacterial infections.

Collaborations: Throughout his career, Plummer has collaborated with notable colleagues, including Matthew Frank Brown and Ye Che. These partnerships have fostered a creative environment that encourages the exchange of ideas and accelerates the advancement of research in antibacterial agents.

Conclusion: Mark Stephen Plummer is a leading figure in the innovation of antibacterial pharmaceuticals. His work on fluoro-pyridinone derivatives and their applications in treating bacterial infections not only contributes to public health but also showcases the importance of innovation in the field of medicine. As he continues to develop groundbreaking solutions at Pfizer Corporation, his influence and expertise will undoubtedly shape the future of antibacterial therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…